LSTA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lisata Therapeutics Inc (LSTA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock's technical indicators show a bearish trend, financial performance is weak with significant revenue and income declines, and there are no positive catalysts or trading signals to suggest immediate upside potential.
The MACD is negative and expanding downward (-0.18), indicating bearish momentum. RSI is extremely oversold at 1.099, which could suggest a potential rebound, but the overall trend remains weak. Moving averages are converging, showing no clear directional trend. The stock is trading below key support levels (S1: 3.673, S2: 3.262), which further indicates bearish sentiment.
NULL identified. No recent news or significant events to drive positive sentiment.
Weak financial performance with a 90% YoY revenue drop, a 35.92% decline in net income, and a 38.18% drop in EPS. No hedge fund or insider buying activity. Technical indicators suggest bearish momentum.
In Q4 2025, revenue dropped by 90% YoY to $100,000, net income fell by 35.92% YoY to -$2,954,000, and EPS declined by 38.18% YoY to -0.34. Gross margin remained flat at 100%. Overall, the financials indicate significant challenges in growth and profitability.
No analyst rating or price target changes available. Wall Street sentiment is neutral with no significant pros or cons noted.
